ESC 2023 Cardiomyopathy Guidelines: Key Updates and Implementation

To summarize and highlight the main changes in the ESC 2023 cardiomyopathy guidelines, focusing on practical implications for clinical implementation.Background. The 2023 ESC guidelines on cardiomyopathies introduce significant updates in diagnostic criteria, terminology, and treatment protocols. These guidelines aim to provide comprehensive approaches for diagnosis and management.Materials and methods. A review of the 2023 ESC guidelines and relevant literature was conducted to outline the changes in diagnostic approaches and treatment standards.Results. The ESC 2023 guidelines introduced revised diagnostic criteria for cardiomyopathies, added new terms such as non-dilated left ventricular cardiomyopathy (NDLVC), and updated treatment specifications, emphasizing personalized approaches and genetic considerations.Conclusion. The ESC 2023 guidelines provide essential updates that refine the diagnosis and treatment of cardiomyopathies, promoting improved clinical practices.